58 related articles for article (PubMed ID: 22430193)
1. Combined analysis of AFP and HCCR-1 as an useful serological marker for small hepatocellular carcinoma: a prospective cohort study.
Zhang G; Ha SA; Kim HK; Yoo J; Kim S; Lee YS; Hur SY; Kim YW; Kim TE; Park YG; Wang J; Yang Y; Xu Z; Song EY; Huang Z; Jirun P; Zhongtian J; Shishi Q; Zhuqingqing C; Lei G; Kim JW
Dis Markers; 2012; 32(4):265-71. PubMed ID: 22430193
[TBL] [Abstract][Full Text] [Related]
2. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis.
Zhu M; Zheng J; Wu F; Kang B; Liang J; Heskia F; Zhang X; Shan Y
J Med Virol; 2020 Dec; 92(12):3596-3603. PubMed ID: 32043608
[TBL] [Abstract][Full Text] [Related]
3. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.
Duarte-Salles T; Misra S; Stepien M; Plymoth A; Muller D; Overvad K; Olsen A; Tjønneland A; Baglietto L; Severi G; Boutron-Ruault MC; Turzanski-Fortner R; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Bamia C; Pala V; Palli D; Mattiello A; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Agudo A; Sánchez-Cantalejo E; Ardanaz E; Gavrila D; Dorronsoro M; Werner M; Hemmingsson O; Ohlsson B; Sjöberg K; Wareham NJ; Khaw KT; Bradbury KE; Gunter MJ; Cross AJ; Riboli E; Jenab M; Hainaut P; Beretta L
Cancer Prev Res (Phila); 2016 Sep; 9(9):758-65. PubMed ID: 27339170
[TBL] [Abstract][Full Text] [Related]
4. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.
Hwang HM; Heo CK; Lee HJ; Kwak SS; Lim WH; Yoo JS; Yu DY; Lim KJ; Kim JY; Cho EW
J Transl Med; 2018 Jun; 16(1):177. PubMed ID: 29954402
[TBL] [Abstract][Full Text] [Related]
5. Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients.
Caponigro V; Tornesello AL; Merciai F; La Gioia D; Salviati E; Basilicata MG; Musella S; Izzo F; Megna AS; Buonaguro L; Sommella E; Buonaguro FM; Tornesello ML; Campiglia P
J Transl Med; 2023 Dec; 21(1):918. PubMed ID: 38110968
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of OPNI in Hepatocellular Carcinoma.
Zhou J; Yang D
Oncology; 2023; 101(8):481-490. PubMed ID: 37454651
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the diagnostic performance of Alpha-1-Antitrypsin in early detection of hepatocellular carcinoma.
Sultan MQ; Charfeddine B; Hussain Al-Salih AR
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):177-185. PubMed ID: 38279446
[TBL] [Abstract][Full Text] [Related]
8. Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.
Lin SY; Xia W; Kim AK; Chen D; Schleyer S; Choi L; Wang Z; Hamilton JP; Luu H; Hann HW; Chang TT; Hu CT; Woodard A; Gade TP; Su YH
Sci Rep; 2023 Dec; 13(1):21585. PubMed ID: 38062093
[TBL] [Abstract][Full Text] [Related]
9. Cellular gp96 upregulates AFP expression by blocking NR5A2 SUMOylation and ubiquitination in hepatocellular carcinoma.
Qian L; Liang Z; Wang Z; Wang J; Li X; Zhao J; Li Z; Chen L; Liu Y; Ju Y; Li C; Meng S
J Mol Cell Biol; 2023 Nov; 15(5):. PubMed ID: 37204028
[TBL] [Abstract][Full Text] [Related]
10. HCC-ART score, a simple, highly sensitive and specific test for early diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Attallah AM; Omran MM; Attallah AA; Abdallah SO; Farid K; Darwish H; El-Dosoky I; Shaker YM
Br J Cancer; 2013 Sep; 109(6):1657-65. PubMed ID: 23982602
[TBL] [Abstract][Full Text] [Related]
11. Research progress of protein induced by vitamin K absence or antagonist II in liver transplantation for hepatocellular carcinoma.
Zhou Z; Liu Q; Liu J; Li W; Cao S; Xu J; Chen J; Xu X; Chen C
Heliyon; 2024 May; 10(9):e30622. PubMed ID: 38726103
[TBL] [Abstract][Full Text] [Related]
12. Bioengineered Organoids Offer New Possibilities for Liver Cancer Studies: A Review of Key Milestones and Challenges.
Jabri A; Khan J; Taftafa B; Alsharif M; Mhannayeh A; Chinnappan R; Alzhrani A; Kazmi S; Mir MS; Alsaud AW; Yaqinuddin A; Assiri AM; AlKattan K; Vashist YK; Broering DC; Mir TA
Bioengineering (Basel); 2024 Apr; 11(4):. PubMed ID: 38671768
[TBL] [Abstract][Full Text] [Related]
13. Development of a Reliable GADSAH Model for Differentiating AFP-negative Hepatic Benign and Malignant Occupying Lesions.
Long X; Zeng H; Zhang Y; Lu Q; Cao Z; Shu H
J Hepatocell Carcinoma; 2024; 11():607-618. PubMed ID: 38549786
[TBL] [Abstract][Full Text] [Related]
14. Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review.
Dominguez DA; Wong P; Melstrom LG
Hepatobiliary Surg Nutr; 2024 Feb; 13(1):39-55. PubMed ID: 38322200
[TBL] [Abstract][Full Text] [Related]
15. Chinese expert consensus statement on the clinical application of AFP/AFP-L3%/DCP using GALAD and GALAD-like algorithm in HCC.
Huang C; Xiao X; Zhou L; Chen F; Wang J; Hu X; Gao C;
J Clin Lab Anal; 2023 Dec; 37(23-24):e24990. PubMed ID: 38063322
[TBL] [Abstract][Full Text] [Related]
16. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
[TBL] [Abstract][Full Text] [Related]
17. The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma.
Ding J; Zhao W
Cancer Manag Res; 2022; 14():2735-2748. PubMed ID: 36133739
[TBL] [Abstract][Full Text] [Related]
18. The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma.
Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; de Castria TB; Zeng B; Zong Z; Zhou T
Ann Transl Med; 2022 Jul; 10(14):766. PubMed ID: 35965795
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database.
Zhang H; Du X; Dong H; Xu W; Zhou P; Liu S; Qing X; Zhang Y; Yang M; Zhang Y
BMC Gastroenterol; 2022 Jul; 22(1):348. PubMed ID: 35854221
[TBL] [Abstract][Full Text] [Related]
20. The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma.
Hua N; Chen A; Yang C; Dong H; He X; Ru G; Tong X; Zhou F; Wang S
Mol Biol Rep; 2022 Aug; 49(8):7911-7919. PubMed ID: 35776395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
